Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537283) titled 'Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy' on April 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: National Cheng-Kung University Hospital
Condition:
Epilepsy
Drugs Resistance
Intervention:
Dietary Supplement: coenzyme Q10
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: February 7, 2023
Target Sample Size: 39
Countries of Recruitment:
Taiwan
To know more, visit https://cl...